New Advocacy Session Premieres at ENDO 2018

To find out how you can become involved in the Society’s advocacy efforts, including our efforts to increase funding for the National Institutes of Health, please join us at ENDO 2018 for a special session hosted by the Advocacy and Public Outreach Core Committee (APOCC).

The purpose of the session is to discuss the Society’s advocacy priorities, how we achieve our “wins,” and how you – our members – can be involved in the process. We will offer four different ways for you to participate, including: advocacy opportunities in Washington, DC, sharing your expertise to advise us on policy and position statements, and using social media as an advocacy tool. This is also a great opportunity to hear from seasoned “endocrine advocates” about their experience in impacting policy both on Capitol Hill and from the comfort of their own home.

The session takes place on Saturday, March 17 from 12:00 to 12:50 p.m. in the Science Hub. If you have questions or would like to participate in this session, please write to the Government & Public Affairs department at [email protected]. We hope you will join us!

You may also like

  • Endocrine Society Advocacy Updates

    Endocrine Society Endorses Right to IVF Act  In June 2024, the Endocrine Society endorsed the Right to IVF Act, introduced by Senators Cory Booker (D-NJ), Patty Murray (D-WA), and Tammy Duckworth (D-IL) to protect and expand nationwide access to fertility treatment, including in vitro fertilization (IVF). The Right to IVF Act would help individuals and families…

  • August 2024 Endocrine Society Advocacy Update

    Revised Version of TROA Passes House Ways & Means Committee On June 27, 2024, the House Ways and Means Committee passed a revised version of the Treat and Reduce Obesity Act (TROA), legislation that would allow Medicare coverage of anti-obesity medications (AOMs), which currently is prohibited under law. The version that passed would only allow…

Find more in